Background Studies have shown that the prevalence of all-variants Alzheimer's disease (AD) and frontotemporal dementia (FTD) both increase with age, even before the age of 65. However, it is not known whether their different clinical presentations all increase in prevalence with age in the same way.Methods We studied the prevalence of the different clinical presentations of young-onset AD and FTD by 5-year age groups in a population-based study identifying all dementia patients with a diagnosis of AD and FTD and symptoms onset before age 65 in the Modena province, Italy. By using regression models of cumulative occurrences, we also estimated age-specific prevalence and compared the growth curves of the clinical presentations.Results The prevalence of all-variants AD increased with age, from 18/1,000,000 in the 40-44 age group to 1411/1,000,000 in the 60-64 age group. The prevalence of all-variants FTD also increased with age, from 18/1,000,000 to 866/1,000,000. An estimation of age-specific prevalence functions of each clinical presentation showed that atypical non-amnestic AD and aphasic FTD grew the most in early ages, followed by the behavioural variant of FTD (bvFTD). Then, around the age of 60, amnestic AD took over and its age-specific prevalence continued to increase disproportionally compared to all the other clinical variants of AD and FTD, which, instead, started to decrease in prevalence.Conclusions Amnestic AD is the clinical presentation that increases the most with advancing age, followed by bvFTD, suggesting that there is a differential vulnerability to the effect of ageing within the same neurodegenerative disease.

Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia / Zamboni, G.; Maramotti, R.; Salemme, S.; Tondelli, M.; Adani, G.; Vinceti, G.; Carbone, C.; Filippini, T.; Vinceti, M.; Pagnoni, G.; Chiari, A.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 271:7(2024), pp. 4326-4335. [10.1007/s00415-024-12364-7]

Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia

Zamboni G.
;
Maramotti R.;Salemme S.;Tondelli M.;Vinceti G.;Carbone C.;Filippini T.;Vinceti M.;Pagnoni G.;
2024

Abstract

Background Studies have shown that the prevalence of all-variants Alzheimer's disease (AD) and frontotemporal dementia (FTD) both increase with age, even before the age of 65. However, it is not known whether their different clinical presentations all increase in prevalence with age in the same way.Methods We studied the prevalence of the different clinical presentations of young-onset AD and FTD by 5-year age groups in a population-based study identifying all dementia patients with a diagnosis of AD and FTD and symptoms onset before age 65 in the Modena province, Italy. By using regression models of cumulative occurrences, we also estimated age-specific prevalence and compared the growth curves of the clinical presentations.Results The prevalence of all-variants AD increased with age, from 18/1,000,000 in the 40-44 age group to 1411/1,000,000 in the 60-64 age group. The prevalence of all-variants FTD also increased with age, from 18/1,000,000 to 866/1,000,000. An estimation of age-specific prevalence functions of each clinical presentation showed that atypical non-amnestic AD and aphasic FTD grew the most in early ages, followed by the behavioural variant of FTD (bvFTD). Then, around the age of 60, amnestic AD took over and its age-specific prevalence continued to increase disproportionally compared to all the other clinical variants of AD and FTD, which, instead, started to decrease in prevalence.Conclusions Amnestic AD is the clinical presentation that increases the most with advancing age, followed by bvFTD, suggesting that there is a differential vulnerability to the effect of ageing within the same neurodegenerative disease.
2024
271
7
4326
4335
Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia / Zamboni, G.; Maramotti, R.; Salemme, S.; Tondelli, M.; Adani, G.; Vinceti, G.; Carbone, C.; Filippini, T.; Vinceti, M.; Pagnoni, G.; Chiari, A.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 271:7(2024), pp. 4326-4335. [10.1007/s00415-024-12364-7]
Zamboni, G.; Maramotti, R.; Salemme, S.; Tondelli, M.; Adani, G.; Vinceti, G.; Carbone, C.; Filippini, T.; Vinceti, M.; Pagnoni, G.; Chiari, A....espandi
File in questo prodotto:
File Dimensione Formato  
Zamboni2024.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 2.39 MB
Formato Adobe PDF
2.39 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1337677
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact